Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Single-Cell Genome Sequencing Market In The Coming Years?
The market size for single-cell genome sequencing has seen a swift expansion in the last few years. The projected growth is from $2.49 billion in 2024 to $2.83 billion in 2025, with a compound annual growth rate (CAGR) of 13.6%. The historical growth can be linked to factors such as an enhanced comprehension of genetic heterogeneity, a surge in the demand for precision medicine, an escalation in cancer research, a rise in the occurrence of infectious diseases, and an increase in healthcare expenditure.
It is forecasted that the single-cell genome sequencing market will witness a rapid surge in its size in the upcoming years. The market size is projected to increase to $5.02 billion by 2029, with a CAGR of 15.4%. This growth during the estimated period can be ascribed to the rise in autoimmune diseases, the escalation of neurological disorders, increased government initiatives and funding, the emergence of contract research organizations (cros), and growing awareness about the potential of scrna-seq. The forecast period is also anticipated to see trends such as advancements in single-cell sequencing technologies, the evolution of single-cell multi-omics technologies, joint efforts to speed up advancements, pioneering solutions, and strategic partnerships among key market players.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12655&type=smp
What Drivers Are Accelerating Expansion Of The Single-Cell Genome Sequencing Market?
The escalation in cancer cases is anticipated to fuel the expansion of the single-cell genome sequencing market. Cancer encompasses a wide range of diseases characterized by abnormal cell growth and division resulting from gene mutations that govern cell division and control the usual cell functions. Detecting genetic variations that occur within individual cancer cells can be significantly assisted by single-cell genome sequencing, given that cancer is fundamentally a genetical alteration disease. For example, the American Cancer Society, a U.S-based cancer combat organization, stated in January 2023 that approximately 1.9 million fresh cancer cases and 609,360 cancer-related deaths were reported in the US in 2022. Moreover, by 2040, roughly 27.5 million new cancer cases and 16.3 million cancer deaths are projected to take place. Consequently, the surge in cancer prevalence is likely to drive the advancement of the single-cell genome sequencing market.
How Is The Global Single-Cell Genome Sequencing Market Broken Down By Segment?
The single-cell genome sequencingmarket covered in this report is segmented –
1) By Type: Instruments; Reagents
2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Quantitative Polymerase Chain Reaction (qPCR); Microarray; Multiple Displacement Amplification (MDA)
3) By Disease Area: Cancer; Immunology; Prenatal Diagnosis; Neurobiology; Microbiology; Other Disease Areas
4) By Application: Circulating Cells; Cell Differentiation Or Reprogramming; Genomic Variation; Subpopulation Characterization; Other Applications
5) By End User: Academic Research Laboratories; Biotechnology Biopharmaceutical Companies; Clinics; Other End Users
Subsegments:
1) By Instruments: Single-Cell Isolation Systems; Sequencing Platforms; Automation And Robotic Systems
2) By Reagents: Library Preparation Kits; Amplification Reagents; DNA Extraction Kits; Quality Control Reagents
Which Trends Are Likely To Redefine Growth Paths In The Single-Cell Genome Sequencing Market?
The rise in technological innovations is a significant trend gaining momentum in the single-cell genome sequencing industry. The prime companies in this market are actively creating technologically innovative solutions to reinforce their standing. For example, in May 2023, Mission Bio Inc., a firm located in the USA that combines genotype and phenotype for cancer studies and biomarker creation, generated a new comprehensive product for genome editing analysis, namely the Tapestri Genome Editing Solution. This revolutionary method is predicted to act as a more potent analytical instrument for producing gene-editing drugs of the future by enabling insights at the single-cell level, thereby adjusting their efficacy and safety.
Which Firms Are Making The Biggest Impact In The Single-Cell Genome Sequencing Market?
Major companies operating in the single-cell genome sequencing market include F Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., DH Life Sciences LLC., Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Bio-Techne Corporation, BGI Genomics Co. Ltd., Fulgent Genetics Inc., 10x Genomics Inc., Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc., Standard BioTools Inc., Singleron Biotechnologies, MGI Tech Co. Ltd, GENEWIZ Inc., Mission Bio Inc., Zymo Research Corporation, Menarini Silicon Biosystems SpA, Novogene Co. Ltd., RareCyte Inc., Fluxion Biosciences Inc., Single Cell Discoveries B.V., Parse Biosciences Inc., BioSpyder Technologies Inc., SeqWell Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report
Which Geographic Regions Are Creating Strong Demand In The Single-Cell Genome Sequencing Market?
North America was the largest region in the single-cell genome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12655&type=smp
Browse Through More Reports Similar to the Global Single-Cell Genome Sequencing Market 2025, By The Business Research Company
Genome Editing Or Genome Engineering Global Market Report 2025
Cell Culture Consumables And Equipment Global Market Report 2025
Cell Based Assays Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model